IPO Year:
Exchange: NASDAQ
F-1/A - NewGenIvf Group Ltd (0001981662) (Filer)
F-1/A - NewGenIvf Group Ltd (0001981662) (Filer)
20-F/A - NewGenIvf Group Ltd (0001981662) (Filer)
F-1/A - NewGenIvf Group Ltd (0001981662) (Filer)
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
20-F - NewGenIvf Group Ltd (0001981662) (Filer)
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
F-1 - NewGenIvf Group Ltd (0001981662) (Filer)
3 - NewGenIvf Group Ltd (0001981662) (Issuer)
BANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that its wholly owned subsidiary, First Fertility PGS Center Limited ("First Fertility"), has launched a strategic expansion initiative targeting the Indian medical tourism market for fertility treatments. This initiative positions NewGen to capitalize on Thailand's rapidly growing fertility tourism sector, which has emerged as a preferred destination for international patients seeking advanced reproductive care. According to ResearchAndMarkets,
BANGKOK, May 07, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on the integration of its recently acquired MicroSort® technology. The strategic integration of this technology – which the company has rebranded to NewGenSort – marks a significant advancement in the company's mission to provide comprehensive, cutting-edge reproductive solutions to couples and individuals throughout Asia. NewGenSort enables the separation of X and Y chromosome-bearing sperm cells prior to fertilization procedures. I
BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it is implementing a reverse stock split of all of the Company's issued and unissued shares at an exchange ratio of one (1) share for ten (10) shares (the "Reverse Stock Split"). The Company's Class A Ordinary Shares will begin trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current ticker symbol "NIVF" at the commencement of trading on May 5, 2025, under the new CUSIP number G0544E121. The Reverse Stock S
BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company's investor relations website at https://investors.newgenivf.com. Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, "With $2.48 million cash with bank and a cash deposit of $1 million with a trading plat
BANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has secured $5.2 million in strategic funding through two separate arrangements with an investor ("the investor"), with the potential to raise a total of up to $30.8 million through the arrangements. These funding arrangements will provide the necessary capital for NewGen to execute on key growth initiatives, including the establishment of a state-of-the-art fertility clinic in Dubai, United Arab Emirates. On April 2, 2025, the Compa
BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger with healthcare company European Wellness Investment Holdings Limited ("EWIHL") and its completion of its acquisition of MicroSort Reproductive Technology. On December 11, 2024, the Company announced its entry into a binding term sheet with EWIHL for a reverse merger, in which EWIHL would on completion hold approximately 61.6% of the Company's equity (the "EWIHL Proposed Transaction"). The completion of
BANGKOK, March 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, announced that it has entered into a strategic collaboration agreement with BOBCARE FERTILITY GROUP LLC ("BOBCARE") to jointly develop fertility services in the Kyrgyzstan market. The collaboration aims to combine NewGen's technical expertise in fertility treatments with BOBCARE's market resources in the region. This strategic partnership is anticipated to contribute to NewGen's market presence over the next three years, improving the competitive position
BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has received a written notice (the "Compliance Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") dated February 27, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As previously announced, the Company was notified by Nasdaq on October 8, 2024, that the Co
BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company") today issued a clarification that, in the press release titled "NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director" issued on February 20, 2025, the Company did not intend to imply that it has already achieved compliance with the Nasdaq Capital Market's $2.5 million minimum stockholders' equity requirement (the "Equity Rule"). However, during its 1st quarter to date, certain NewGen debtholders converted $2.3 million of debt to equity and the Company has drawn down approximately $4.3 million from its Equity Line of Credit with White Lion
Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane